Leica Biosystems: Difference between revisions
Apollo3006 (talk | contribs) new article |
(No difference)
|
Revision as of 20:10, 16 July 2015
| Company type | Subsidiary GmbH |
|---|---|
| Industry | Biotechnology, Digital pathology |
| Founded | 1989 |
| Headquarters | Wetzlar, Germany |
Key people | Mathias Weber – President; Gert Schaumberg – Vice President Finance CFO |
| Products | Microtome; Cryostat; Vibratome |
| Parent | Danaher |
| Website | www |
Leica Biosystems (founded 1989) is a biotechnology company that develops and supplies clinical diagnostics to the pathology market. It is also a research, instrument, and medical device company and a subsidiary of Leica Microsystems GmbH.
Company Description
The company has headquarters in Nussloch, Germany with operations in the United Kingdom, Australia, China, Singapore, Illinois, and Boston. A temporary research and development facility concentrating on cancer diagnostics has been in operation in Danvers, Massachusetts since August 2012.[2]
The Massachusetts facility partners with Galena Biopharma to develop companion diagnostics for a breast cancer vaccine.[3]
Leica Biosystems acquired Aperio, an ePathology solutions company, in October 2012.[4] In October 2014, the company announced they were purchasing Devicor Medical Products, which is headquartered in Cincinnati and makes medical devices used in breast biopsies.[5]
- ^ Leica microsystems.com
- ^ Seiffert, Don. “Leica Biosystems plans to expand R&D facility in Mass.” Boston Business Journal. Feb. 1, 2013
- ^ Weintraub, Karen. “Leica Biosystems plans R&D expansion in area.” The Boston Globe. Feb. 25, 2013
- ^ [ http://finance.yahoo.com/news/leica-biosystems-completes-acquisition-aperio-215809085.html “Leica Biosystems completes acquisition of Aperio.”] Yahoo Finance. Oct. 24, 2012
- ^ Collins, Allison. “Leica Biosystems Adds GTCR-Backed Devicor Medical Products.” Mergers and Acquisitions. Oct. 28, 2014